FDA plans 24 public meetings in November
The U.S. Food and Drug Administration (FDA) has scheduled 24 public meetings, conferences and workshops for November, the agency reported.
Latest News
FDA Update: September inspection citations
The U.S. Food and Drug Administration (FDA) inspects numerous facilities around the nation to ensure that they comply with current rules governing FDA-regulated products.
FDA Update: September medical device recalls
Recalls of medical devices occur when a company sees a need to either take corrective action or remove a potentially hazardous device from the market, according to the U.S. Food and Drug Administration (FDA).
FDA plans 19 public meetings in October
Nineteen public meetings, conferences or workshops sponsored by the U.S. Food and Drug Administration have been scheduled for October, the FDA reported.
Torrent's recall of drug to treat hypertension expanded
The recall of medications manufactured by Torrent Pharmaceuticals Ltd. to treat high blood pressure conditions has been expanded, the U.S. Food and Drug Administration reported.
FDA Update: August inspection citations
The U.S. Food and Drug Administration inspects numerous facilities around the nation to ensure that they comply with current rules governing FDA-regulated products.
FDA Update: July facility inspection results
The U.S. Food and Drug Administration inspects numerous facilities around the nation to ensure that they comply with current rules governing FDA-regulated products.
FDA Update: August medical device recalls
Recalls of medical devices occur when a company sees a need to either take corrective action or remove a potentially hazardous device from the market, according to the U.S. Food and Drug Administration.
FDA plans 17 public meetings in September
Seventeen public meetings, conferences or workshops sponsored by the U.S. Food and Drug Administration have been scheduled for September, the FDA reported.
FDA Update: June facility inspection results
The U.S. Food and Drug Administration inspects numerous facilities around the nation to ensure that they comply with current rules governing FDA-regulated products.
FDA Update: generic drug approvals
The U.S. Food and Drug Administration periodically provides information on the pace of generic drug approvals through its website.
FDA Update: July medical device recalls
Recalls of medical devices occur when a company sees a need to either take corrective action or remove a potentially hazardous device from the market, according to the U.S. Food and Drug Administration.
FDA plans 6 public meetings in August
Six public meetings, conferences or workshops sponsored by the U.S. Food and Drug Administration have been scheduled for August, the FDA reported.
30 food, dietary supplement recalls initiated
Food producers carried out 30 food or dietary supplement product recalls over the past month, according to the U.S. Food and Drug Administration.
6 drugs recalled during June, FDA reports
Six drugs were recalled in June to protect patients from possible harmful defects associated with the products, the U.S. Food and Drug Administration reported.
FDA launched 7 foodborne disease probes in first 6 months of 2019
Seven outbreaks of foodborne illnesses have been reported so far this year, according to the U.S. Food and Drug Administration.
46 food, dietary supplement recalls initiated
Food producers carried out 46 food or dietary supplement product recalls over the past month, according to the U.S. Food and Drug Administration.
FDA Update: May medical device recalls
Recalls of medical devices occur when a company sees a need to either take corrective action or remove a potentially hazardous device from the market, according to the U.S. Food and Drug Administration.
5 drugs recalled during May, FDA reports
Five drugs were recalled in May to protect patients from possible harmful defects associated with the products, the U.S. Food and Drug Administration reported.
New regulations ramp up FDA generic drug approval process, study finds
The Food and Drug Administration granted full approval to nearly 800 generic drugs in fiscal year 2018, a 90 percent increase over the same time period four years ago, according to a recent analysis by PricewaterhouseCoopers LLP.